Brainstorm Cell Therapeutics CEO Chaim Lebovits' 2021 pay falls 47% to $1.1M
Brainstorm Cell Therapeutics reports 2021 executive compensation
By ExecPay News
Published: December 13, 2022
Brainstorm Cell Therapeutics reported fiscal year 2021 executive compensation information on December 13, 2022.
In 2021, three executives at Brainstorm Cell Therapeutics received on average a compensation package of $935K, a 38% decrease compared to previous year.
Average pay of disclosed executives at Brainstorm Cell Therapeutics
Chaim Lebovits, Chief Executive Officer, received $1.1M in total, which decreased by 47% compared to 2020. 44% of Lebovits' compensation, or $500K, was in salary. Lebovits also received $250K in bonus, $110K in stock awards, as well as $268K in other compensation.
Ralph Kern, Chief Medical Officer, received a compensation package of $939K, which decreased by 39% compared to previous year. 53% of the compensation package, or $500K, was in salary.
Stacy Lindborg, EVP, Chief Development Officer, earned $737K in 2021, a 15% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on December 13, 2022.